NCPA Voices Concerns Over Medicare Drug Price Negotiation Plan Implementation

Washington, D.C. – The National Community Pharmacists Association (NCPA) has expressed concerns regarding the rollout of the Medicare Drug Price Negotiation Plan. Ronna Hauser, PharmD, the Senior Vice President of Policy and Pharmacy Affairs at NCPA, outlined the association’s reservations about the plan’s practical implementation. Hauser explained that NCPA’s concerns stem from potential challenges that independent pharmacies may face as the Medicare Drug Price Negotiation Plan is enacted. She stated that these challenges could impact the pharmacies’ ability to serve their patients effectively and efficiently, adding that NCPA will continue to monitor the situation as the plan moves forward.

Newsflash | Powered by GeneOnline AI
Date: April 23, 2025

Related posts:

Protein AP2A1 Linked to Reversing Cellular Aging Former NIH Director Francis Collins Announces Retirement, Advocates for Respect Towards Agency Staff Data Clean Rooms Revolutionize Secure Healthcare Data Sharing Study Finds Timing of Prenatal Stress Influences Infant Stress Responses by Gender

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後